Navigation Links
Ridge Diagnostics, Inc. Awarded Phase 2 National Science Foundation Grant
Date:4/23/2009

Grant Supports First Blood Test for Depression

SAN DIEGO, April 23 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company commercializing its first-in-class, proprietary blood test for depression or Major Depressive Disorder(MDD), has been awarded a Phase 2, National Science Foundation, Small Business Innovation Research (SBIR) Program grant. The grant will be used to further the clinical development and commercialization of its blood test for depression, the first blood test for any neuropsychiatric disorder.

In January 2009, the company completed the commercial launch of its CLIA certified laboratory in Research Triangle Park, NC. The laboratory provides testing information to physicians, pharmaceutical companies and clinical research organizations. The test can be used in pharmaceutical research to objectively identify and stratify patient populations to enhance drug research and clinical studies. It is intended to be used by psychiatrists and primary care physicians to diagnose and monitor treatment of patients with depression. A biological test based upon the physiological changes caused by depression could drive the earlier diagnosis, and treatment management of the over 20 million adults in the U.S. facing this disease.

"We are pleased to once again, announce the National Science Foundation's recognition of Ridge's technological accomplishments. This prestigious grant will enable us to further the clinical development of our blood tests and build on our CLIA laboratory infrastructure to support our growing business," stated Stan Sewitch, President and CEO of Ridge.

Ridge Diagnostics, Inc. is a neurodiagnostic company commercializing a breakthrough, first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD). The company's products are derived from a proprietary Human Biomarker Library and Hyper-Mapping(TM) technology. Ridge intends to develop a comprehensive neuropsychiatric disease diagnostic franchise. Ridge Diagnostics testing services are provided through its CLIA certified laboratory in North Carolina, then through diagnostic test kits sold worldwide. The company is located in San Diego, CA and Research Triangle Park, NC.


'/>"/>
SOURCE Ridge Diagnostics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Parkinsons Disease Foundation Awards $300,000 in Bridge Funding for Innovative Research Projects
2. Cambridge Laboratories Announces Approval of Tetrabenazine in Spain
3. Taligen Therapeutics Initiates Corporate Growth Plan with Appointment of Abbie Celniker, Ph.D., as CEO and Establishment of Cambridge, Mass., Headquarters
4. Thoratec Announces FDA Approval of HeartMate II(R) for Bridge-To-Transplantation
5. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
6. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
7. Pressure BioSciences, Inc. Announces $850,000 NIH SBIR Phase II Award for the Development of a New PCT-dependent System for Improved Biomarker Discovery, Diagnostics, and Drug Discovery
8. Global Health Research Foundation Awarded $25,000 Grant From Westly Foundation to Study Asthma in Californias Central Valley
9. KGI Professor Ian Phillips Awarded Defense Grants for Medical Combat Research
10. K-State Researchers Awarded Nearly $1 Million to Test Remedies, Investigate Link Between E. Coli and Distillers Grains
11. Modigene Awarded Israeli Government Grant to Support Development of Its Longer-Acting Interferon Beta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... 2017 FinancialBuzz.com News Commentary ... due to the significant development and innovation in EP ... Research, the global electrophysiology market was worth $3.42 billion ... by 2022, with a GAGR of 13.4%. Electrophysiology is ... abnormal heartbeats or arrhythmia. The report indicates that in ...
(Date:3/22/2017)... EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, ... Canada , today announced two new real-world data analyses ... 65 th Annual Pacific Coast Reproductive Society (PCRS) Meeting ... 24 th .   The results being presented are ... 2009 to December 2015 containing data from 15 fertility clinics ...
(Date:3/22/2017)... March 22, 2017  Levine Cancer Institute today ... unit designed to address lung cancer diagnosis, treatment ... Carolinas. The mobile lung unit is the first-of-its-kind ... and treatment interventions through integrated mobile technology, traditional ... Financial barriers and a lack of public transportation ...
Breaking Medicine Technology:
(Date:3/23/2017)... ... 23, 2017 , ... “The Trainer”: an electrifying and suspenseful gunslinger novel ... writer with an active imagination and an enthusiasm for action and adventure stories. ... Wild Bill Hart, who sat looking at the thirty-three notches that lined the edges ...
(Date:3/22/2017)... (PRWEB) , ... March 23, 2017 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today announced ... BioPharma Asia Convention, currently taking place at the Suntec Singapore International Exhibition & ...
(Date:3/22/2017)... ... March 22, 2017 , ... Soriant recognizes that ... bypasses that. Healthcare facilities across the country are always forced to focus ... and hospitals, across the country, an efficient and quick way to estimate savings ...
(Date:3/22/2017)... ... March 22, 2017 , ... The Rett Syndrome ... devastating neurological disorder that afflicts 350,000 individuals worldwide. Rett Syndrome is caused ... almost exclusively strikes females. Following a normal infancy, Rett Syndrome takes effect ...
(Date:3/22/2017)... PA (PRWEB) , ... March 22, 2017 , ... Last ... according to a US Department of Agriculture report. While excess dairy can be ... play a role. Lactose sensitivity is the inability to properly digest lactose, a sugar ...
Breaking Medicine News(10 mins):